Institute of Burn Research, State Key Laboratory of Trauma, Burns and Combined Injury, Southwest Hospital, Third Military Medical University(Army Medical University), Chongqing, China.
Department of plastic Surgery, Southwest Hospital, Third Military Medical University(Army Medical University), Chongqing, China.
Int J Biol Sci. 2019 Jan 1;15(2):493-506. doi: 10.7150/ijbs.29404. eCollection 2019.
CD9 is a trans-membrane protein, and has recently been implicated in different physiological and cellular processes, such as cell migration and adhesion. According to previous study, down-regulation of CD9 contributes to keratinocyte migration, critical for wound re-epithelialization. Nevertheless, it is widely believed that tetraspanin CD9 does not have ligands or function as the cell surface receptor, rather it is thought to associate with other transmembrane molecules, thereby mediate keratinocyte migration. Little is known about how CD9 associates with transmembrane molecules in migratory keratinocytes. Here, using confocal microscopy, we observed that tetraspanin CD9 and ADAM17 co-localized on the surface of keratinocytes in the course of wound repair and . Co-immunoprecipitation experiments demonstrated a direct association between CD9 and ADAM17 in HaCaT cells and C57-MKs. Functional studies revealed that down-regulation or over-expression of CD9 exerted negative regulatory effects on ADAM17 sheddase activity. This activity is involved in CD9-regulated cell motility and migration. Further studies found that ADAM17 inhibitor-TAPI-2 or siADAM17 significantly abolished the enhanced effect of keratinocyte migration induced by CD9 down-regulation. Meanwhile, the sheddase activity of ADAM17 was inhibited by TAPI-2, which decreased this release of AREG and HB-EGF in CD9-silenced HaCat cells and C57-MKs. Importantly, neutralizing antibody against HB-EGF significant weakened keratinocyte migration and motility in CD9-silenced keratinocytes, and the inhibition of CD9-regulated keratinocyte migration by siADAM17 was rescued by addition of recombinant HB-EGF, activating EGFR/ERK pathway. Collectively, our results suggest that ADAM17 sheddase activity is activated by down-regulation of CD9, thereby mediating shedding of HB-EGF and activation of EGFR/ERK signaling, which crucially affects the keratinocyte migration and wound healing.
CD9 是一种跨膜蛋白,最近被牵连到不同的生理和细胞过程中,例如细胞迁移和黏附。根据之前的研究,CD9 的下调有助于角质形成细胞的迁移,这对伤口再上皮化至关重要。然而,人们普遍认为四跨膜蛋白 CD9 没有配体或作为细胞表面受体发挥作用,而是认为它与其他跨膜分子结合,从而介导角质形成细胞的迁移。目前还不清楚 CD9 如何与迁移角质形成细胞中的跨膜分子结合。在这里,我们使用共聚焦显微镜观察到,在伤口修复过程中,四跨膜蛋白 CD9 和 ADAM17 在角质形成细胞表面共定位。免疫共沉淀实验表明,CD9 和 ADAM17 之间存在直接关联 HaCaT 细胞和 C57-MKs。功能研究表明,下调或过表达 CD9 对 ADAM17 脱落酶活性具有负调节作用。这种活性涉及 CD9 调节的细胞运动和迁移。进一步的研究发现,ADAM17 抑制剂-TAPI-2 或 siADAM17 显著消除了 CD9 下调诱导的角质形成细胞迁移增强的作用。同时,TAPI-2 抑制了 ADAM17 的脱落酶活性,减少了 CD9 沉默的 HaCat 细胞和 C57-MKs 中 AREG 和 HB-EGF 的释放。重要的是,中和抗体针对 HB-EGF 显著削弱了 CD9 沉默的角质形成细胞中的迁移和运动,siADAM17 抑制 CD9 调节的角质形成细胞迁移通过添加重组 HB-EGF 得到挽救,激活了 EGFR/ERK 通路。总之,我们的研究结果表明,CD9 的下调激活了 ADAM17 的脱落酶活性,从而介导了 HB-EGF 的脱落和 EGFR/ERK 信号的激活,这对角质形成细胞的迁移和伤口愈合至关重要。